Lilly Korea said the Ministry of Food and Drug Safety approved its Retevmo 40mg and 80mg as Korea's first RET (Rearranged during Transfection) inhibitor treatment on Friday.Under the approval, hospitals can use Retevmo in treating adult patients with metastatic RET fusion-positive non-small cell lun
The government will exempt overseas travelers who have completed their Covid-19 vaccinations and registered their vaccination history from the mandatory weeklong self-isolation from March. 21.Until now, the government has put all foreign arrivals in self-isolation for seven days, regardless of their
The medical field is recently accelerating the transition to precision care based on rapidly developing technology.The first step in precision care is to provide an accurate diagnosis and increase convenience for medical staff and patients with cutting-edge technology.While only large general hospit
The Korea International Medical and Hospital Equipment Show (KIMES) is succeeding in redrawing the interests of foreign buyers and participants in the annual exhibition, overcoming the failure of 2021.Last year, the exhibition organizers pushed ahead with KIMES 2021 amid the Covid-19 crisis and a gl
VUNO said it has obtained the Ministry of Food and Drug Safety certification for VUNO Med-LungQuant, an artificial intelligence (AI)-based lung computed tomography (CT) quantification.The solution automatically analyzes lung CT images based on AI to segment characteristic areas in CT images and prov
As the Covid-19 pandemic approaches its peak pushed by the Omicron wave, the government sped up the conversion of its treatment system for confirmed patients on Thursday."Now is the time for the entire medical staff at hospitals to come forward to treat the Omicron patients," Minister of Health and
Amgen Korea, which had conquered Korea's osteoporosis treatment market with Prolia and Evenity, set a new milestone last year by becoming the first company to surpass 100 billion won ($81.3 million) in annual sales.According to IQVIA, a drug market research company, sales of Prolia's (ingredient: de
The 37th Korea International Medical and Hospital Equipment Show (KIMES 2022) opened at the COEX in southern Seoul on Thursday.Co-organized by the Korea Medical Devices Industrial Cooperation Association (KMDICA), Korea Medical Industry Association (KMDIA), and Korea E&EX, the annual event aims to p
Hanmi Pharmaceutical said the company would market its blockbuster hypertension drug Amosartan in China, making it the first homegrown combination therapy to enter the Chinese blood pressure treatment market.Beijing Hanmi Pharmaceutical received market approval for the treatment from China's Nationa
The number of critically ill Covid-19 patients surpassed 1,000 for the first time in 64 days on Tuesday as the Omicron variant continued to spread rapidly across the country.The Korea Disease Control and Prevention Agency (KDCA) confirmed 1,007 severe and critical cases, up 52 from Monday. The figur
A three-university research team has successfully synthesized a nanozyme and used it to develop a paper-based disease substance detection sensor, which can detect six target substances simultaneously.Enzymes act as catalysts for various chemical reactions in a person’s body. Still, recently, reports
Pharma Essentia Korea said that the U.S. National Comprehensive Cancer Network (NCCN) guidelines have updated Besremi (Ingredient: ropeginterferon alfa-2b) as a recommended option for the treatment of polycythemia vera (PV).According to the company, Besremi is the only first-line treatment and next-
Daewoong Pharmaceutical and Affyxell Therapeutics said they would cooperate with Seoul National University Hospital (SNUH) in developing regenerative medicine and advanced biopharmaceuticals.The three have signed a memorandum of understanding to establish a regenerative medical infrastructure and co
Bridge Biotherapeutics said that it signed an exclusive option-to-license agreement for Cellion BioMed’s ion channel modulator to develop a novel therapy for multiple fibrotic diseases, including idiopathic pulmonary fibrosis (IPF).The substance, named BBT-301, is an innovative drug candidate that h
The government will start providing Covid-19 vaccines to children aged 5-11 soon, starting with high-risk groups due to weakened immunity, Korea Disease Control and Prevention Agency (KDCA) Commissioner Jeong Eun-kyeong said Monday.Jeong said the agency is preparing an inoculation plan for 5- to 11-
The 12th Global Healthcare and Medical Tourism Conference (Medical Korea 2022) will open on Thursday, organized by the Korea Health Industry Development Institute (KHIDI) and hosted by the Ministry of Health and Welfare.Medical Korea 2022 comprises academic conferences, briefing sessions, seminars,
Daewoong Pharmaceutical’s U.S. partner Evolus said Monday that their botulinum toxin product Jeuveau (Nabota in Korea) showed immense sales growth last year, expecting the pace would continue this year.According to Evolus, the sales of Jeuveau in the U.S. reached $99.7 million last year, up 76 perce
Bayer, long a household word in cardiovascular diseases and women's health, is distinguishing itself in new blockbuster candidates and novel platforms while adding to its traditional strength.For instance, the global pharmaceutical giant is undergoing crucial changes by replacing its current blockbu
Hanmi Pharmaceutical said that it has started marketing SynoJoynt, an osteoarthritis injection treatment, with Arthrex, a global medical device company, in the U.S.The treatment, also known as Hyalrheuma in Korea, is a high-molecular-weight hyaluronic acid product produced by Hanmi using its advance
The government decided to push back the business curfew on cafes, restaurants, and other multiuse facilities by an hour to 11 p.m. from Saturday.The eased distancing rules follow the government's decision to temporarily halt the vaccine mandate applied to multiuse facilities and gatherings from Tues